Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureWeiliang Xia
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Anesthesia in cases of poor surgical risk: some suggestions for decreasing the risk
10.1097/00000542-194209000-00032 · 1942
On the use of Ringer-Locke solutions containing hemoglobin as a substitute for normal blood in mammals
10.1002/jcp.1030050309 · 1934
First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative
10.1182/bloodadvances.2022007977 · 2022
A broad diversity in oxygen affinity to haemoglobin
10.1038/s41598-020-73560-9 · 2020
The effect of rigid red blood cells on platelet adhesion in blood flow and implications in sickle cell disease
10.1182/blood-2019-128733 · 2019
A therapeutic oxygen carrier isolated from Arenicola marina decreased P. gingivalis induced inflammation and tissue destruction
10.1038/s41598-020-71593-8 · 2020
Regulatory mechanisms of hemoglobin oxygen affinity in acidosis and alkalosis
10.1172/jci106540 · 1971
A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol
2005
Hemoglobin-based oxygen carriers: from mechanisms of toxicity and clearance to rational drug design
10.1016/j.molmed.2010.07.006 · 2010
10.1007/978-3-030-95975-3_28
10.1007/978-3-030-95975-3_28 · 2022
Fluid resuscitation for hemorrhagic shock in tactical combat casualty care: TCCC guidelines change 14-01–2 June 2014
2014
A phase I study of oxidized raffinose cross-linked human hemoglobin
10.1097/00003246-200007000-00017 · 2000
Perfluorocarbon-based oxygen carriers: review of products and trials
10.1111/j.1525-1594.2009.00944.x · 2010
Stop the bleed”: a U.S. Military installation’s model for implementation of a rapid hemorrhage control program
10.1093/milmed/usy185 · 2019
Hemoglobin-based oxygen carriers: where are we now in 2023?
10.3390/medicina59020396 · 2023
Unresolved referenced work
2022
The anti-tumoral effects of the oxygen carrier YQ23 in a triple-negative breast cancer syngeneic model
10.21037/tcr-20-2768 · 2021
Unresolved referenced work
2022
Unresolved referenced work
2025
Unresolved referenced work
2021
Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery
1999
Unresolved referenced work
2023
Unresolved referenced work
2025
Unresolved referenced work
2022
Red blood cell storage time and transfusion: current practice, concerns and future perspectives
2017
Red blood cells stored 35 days or more are associated with adverse outcomes in high-risk patients
10.1111/trf.13559 · 2016
Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion
10.1111/trf.14768 · 2018
Blood management in high-risk surgery
10.1001/jama.2021.25299 · 2022
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care
10.1056/nejm199902113400601 · 1999
Unresolved referenced work
2022
Large-scale in vitro production of red blood cells from human peripheral blood mononuclear cells
10.1182/bloodadvances.2019000689 · 2019
10.1007/978-3-030-95975-3_18
10.1007/978-3-030-95975-3_18 · 2022
A hemoglobin-based multifunctional therapeutic: polynitroxylated pegylated hemoglobin
10.1111/j.1525-1594.2011.01307.x · 2012
Ensuring a safe and sufficient global blood supply
10.1056/nejmp2403596 · 2024
Blood substitutes: basic science, translational studies and clinical trials
10.3389/fmedt.2022.989829 · 2022
HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery
2008
10.1007/978-3-030-95975-3_12
10.1007/978-3-030-95975-3_12 · 2022
Unresolved referenced work
2024
Open and remotely accessible neuroplatform for research in wetware computing
10.3389/frai.2024.1376042 · 2024
In vitro neurons learn and exhibit sentience when embodied in a simulated game-world
10.1016/j.neuron.2022.09.001 · 2022
Preparation and exchange transfusion effect of a double polymerization human umbilical cord haemoglobin of red blood cell substitute
10.1080/21691401.2023.2201599 · doi-reference
Perfluorocarbon-based oxygen carriers: what is new in 2024?
10.1016/j.jatmed.2024.02.003 · doi-reference
The protective effect of a novel cross-linked hemoglobin-based oxygen carrier on hypoxia injury of acute mountain sickness in rabbits and goats
10.3389/fphys.2021.690190 · doi-reference
There will be blood
10.1126/science.adr4067 · doi-reference
Blood shortages and donation in China
10.1016/s0140-6736(16)30416-0 · doi-reference
OxyVita(®)C, a next-generation haemoglobin-based oxygen carrier, with coagulation capacity (OVCCC). modified lyophilization/spray-drying process: proteins protection
10.1080/21691401.2017.1339052 · doi-reference
OxyVita? Hb: a step forward in delivering oxygen carrying capacity for therapeutic applications
10.1142/9789811228698_0042 · doi-reference
Pet owners’ awareness of animal blood banks and their motivations towards animal blood donation
10.1136/vr.105139 · doi-reference
De novo design of protein structure and function with RFdiffusion
10.1038/s41586-023-06415-8 · doi-reference
Polynitroxylated PEGylated hemoglobin protects pig brain neocortical gray and white matter after traumatic brain injury and hemorrhagic shock
10.3389/fmedt.2023.1074643 · doi-reference
The role of pet blood bank UK
10.1111/vnj.12142 · doi-reference
Joint trauma system clinical practice guideline (JTS CPG): prehospital blood transfusion. 30 October 2020
10.55460/p685-l7r7 · doi-reference
Mini-review on the properties and possible applications of therapeutic oxygen carrier Hemarina-M101
10.1016/j.transci.2020.103016 · doi-reference
Methemoglobin—it’s not just blue: a concise review
10.1002/ajh.20738 · doi-reference
Oxygen-carrying blood substitutes: a microvascular perspective
10.1517/14712598.4.7.1147 · doi-reference
An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cells
10.1038/ncomms14750 · doi-reference
Current status of artificial O2 carriers
10.1016/j.atc.2005.01.004 · doi-reference
Machine perfusion of donor organs for transplantation
10.1111/aor.13894 · doi-reference
Milestones for clinical translation of the artificial placenta
10.1016/j.siny.2022.101408 · doi-reference
Polynitroxylated pegylated hemoglobin: a novel neuroprotective hemoglobin for acute volume-limited fluid resuscitation after combined traumatic brain injury and hemorrhagic hypotension in mice
10.1097/ccm.0b013e318206b1fa · doi-reference
Hemoglobin-based oxygen carriers: current state-of-the-art and novel molecules
10.1097/shk.0000000000001009 · doi-reference
Integrative multi-omics profiling in human decedents receiving pig heart xenografts
10.1038/s41591-024-02972-1 · doi-reference
Hemoglobin and the paracrine and endocrine functions of nitric oxide
10.1056/nejmcibr023045 · doi-reference
The influence of the storage lesion(s) on pediatric red cell transfusion
10.1097/mop.0000000000000224 · doi-reference
Assessing the global burden of hemorrhage: the global blood supply, deficits, and potential solutions
10.1177/20503121211054995 · doi-reference
A hemoglobin-based oxygen carrier sensitized cisplatin based chemotherapy in hepatocellular carcinoma
10.18632/oncotarget.19672 · doi-reference
Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution
10.1097/00003246-199612000-00011 · doi-reference
Towards manufactured red blood cells for the treatment of inherited anemia
10.3324/haematol.2020.268847 · doi-reference
Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation
10.1001/archinternmed.2012.2449 · doi-reference
An extra-uterine system to physiologically support the extreme premature lamb
10.1038/ncomms15112 · doi-reference
Cellular dynamics in pig-to-human kidney xenotransplantation
10.1016/j.medj.2024.05.003 · doi-reference
Erythromer (EM), a nanoscale bio-synthetic artificial red cell: proof of concept and in vivo efficacy results
10.1182/blood.v128.22.1027.1027 · doi-reference
Autologous blood donations prior to elective cardiac surgery: safety and effect on subsequent blood use
10.1001/jama.1989.03430140081029 · doi-reference
Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial
10.1016/j.jamcollsurg.2008.09.023 · doi-reference
Current perspectives of artificial oxygen carriers as red blood cell substitutes: a review of old to cutting-edge technologies using in vitro and in vivo assessments
10.1007/s40005-022-00590-y · doi-reference
Therapeutic delivery of oxygen using artificial oxygen carriers demonstrates the possibility of treating a wide range of diseases
10.1186/s12951-024-03060-9 · doi-reference
PEGylated carboxyhemoglobin bovine (sanguinate): results of a phase I clinical trial
10.1111/aor.12341 · doi-reference
Thriving in oxygen while preventing ROS overproduction: no two systems are created equal
10.3389/fphys.2022.874321 · doi-reference
Splenic development and injury in premature lambs supported by the artificial placenta
10.1016/j.jpedsurg.2019.02.041 · doi-reference
Artificial oxygen carriers, from nanometer- to micrometer-sized particles, made of hemoglobin composites substituting for red blood cells
10.1016/j.partic.2021.08.010 · doi-reference